Arthritis gene therapy

Drugs of Today

Volumn 35, Issue 4-5, 1999, Pages 353-360

  Robbins, Paul D ^a   Evans, Christopher H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 4; LIPOSOME; RECOMBINANT LYMPHOTOXIN;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTHRITIS; CLINICAL TRIAL; CLONING VECTOR; CONFERENCE PAPER; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RETROVIRUS; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; T LYMPHOCYTE;

EID: 0032778005     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.4-5.552209     Document Type: Conference Paper

References (36)

1. Lydyard, P.M., Edwards, J.C.W. The pathophysiology of rheumatoid arthritis. Clin Exp Rheum 1994, 12: S55-8.
2. Kwoh, K. et al. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996, 39: 713-22.
3. Moreland, L.W. et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. New Engl J Med 1997, 337: 141-7.
4. Elliott, M.J. et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α. Lancet 1994, 344: 1105-10.
5. Campion, G.V., Lebsack, M.E., Lookabaugh, J., Gordon, G., Catalano, M., and the IL-1Ra Arthritis Study Group. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1996, 39: 1092-101.
6. Joosten, L.A.B., Helsen, M.M.A., Van de Loo, F.A.J., van den Berg, W.B. Anti-cytokine treatment of established type II collagen induced arthritis in DBA/1 mice. Arthritis Rheum 1996, 39: 797-809.
7. Van Roon, J.A., van Roy, J.L., Gmelig-Meyling, F.H., Lafeber, F.P., Bijlsma, J.W. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996, 39: 829-35.
8. Maini, R.N., Paulus, H., Breedveld, F.C. et al. rHuIL-10 in subjects with active rheumatoid arthritis: a phase I and cytokine response study. Arthritis Rheum 1997, 40 (Suppl.): S224.
9. Bandara, G., Mueller, G.M., Galea-Lauri, J. et al. Intraarticular expression of the interleukin-1 receptor antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 1993, 90: 10764-8.
10. Otani, K., Nita, I., Macaulay, W. et al. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 1996, 156: 3558-62.
11. Evans, C.H., Robbins, P.D. Gene therapy for arthritis. J Rheumatol 1994, 21: 779-82.
12. Robbins, P.D., Ghivizzani, S.C., Evans, C.H. Gene transfer to joints. Drug News Perspect 1997, 10: 283-92.
13. Robbins, P.D., Tahara, H., Ghivizzani, S.C. Viral vectors for gene therapy. Trends Biotech 1998, 16: 35-40.
14. Roessler, B.J., Allen, E.D., Wilson, J.M., Hartman, J.W., Davidson, B.L. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 1993, 92: 1085-92.
15. Roessler, B.J., Hartman, J.W., Vallance, D.K., Latta, J.M., Janich, S.L., Davidson, B.L. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum Gene Ther 1995, 6: 307-16
16. Ghivizzani, S.C., Lechman, E.R., Kang, R. et al. Direct adenoviral-mediated gene transfer of IL-1 and TNF-α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci USA 1998, 95: 4613-8.
17. Wilson, J.M. Adenoviruses as gene-delivery vehicles. New Engl J Med 1996, 334: 1185-7.
18. Wang, Q., Finer, M.H. Second generation adenovirus vectors. Nat Med 1996, 2: 714-6.
19. Glorioso, J.C., DeLuca, N.A., Fink, D.J. Development and application of herpes simplex virus vectors for human gene therapy. Ann Rev Microbiol 1995, 49: 675-710.
20. Glorioso, J.C., Robbins, P.D., Krisky, D. et al. Progress in the development of herpes simplex viurs gene vectors for treatment of rheumatoid arthritis. Adv Drug Deliv Rev 1997, 27: 41-57.
21. Ghivizzani, S.C., Lechman, E.R., Tio, C. et al. Direct retroviral mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy. Gene Ther 1997, 4: 977-82.
22. Yovandich, J., O'Malley, B. Jr., Sikes, M., Ledley, F.D. Gene transfer to synovial cells by intra-articular administration of plasmid DNA. Hum Gen Ther 1995, 6: 603-10.
23. Nita, I., Ghivizzani, S., Galea-Lauri, J. et al. Direct gene delivery to synovium: An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 1995, 39: 820-8.
24. Makarov, S.S., Olsen, J.C., Johnston, W.N. et al. Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist. Proc Natl Acad Sci USA 1996, 93: 402-6.
25. Müller-Ladner, U., Roberts, C.R., Franklin, B.N. et al. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 1997, 158: 3492-8.
26. Whalen, J.D., Carlos, C.A., Robbins, P.D., Evans, C.H. Periarticular gene therapy with viral IL-10 can prevent collagen-induced arthritis. Arthritis Rheum 1996, 39 (Suppl.): S158.
27. Müller-Ladner, U., Franklin, B.N., Roberts, C.R. et al. Gene transfer of interleukin-10 into human synovial fibroblasts and implantation into the SCID mouse. Arthritis Rheum 1996, 39 (Suppl.): S160.
28. Zhang, H., Yang, Y., Horton, J.L. et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand. J Clin Invest 1997, 100: 1951-7.
29. Chernajovsky, Y., Adams, G., Podhajcer, O., Mueller, G., Robbins, P.D., Feldmann, M. Inhibition of transfer of collagen-induced arthritis into SCID mice by gene transfer of spleen cells with retrovirus expressing soluble human tumor necrosis factor receptor. Gene Ther 1995, 2: 731-5.
30. Chernajovsky, Y., Adams, G., Triantaphyllopoulos, K., Ledda, F., Podhajcer, O.L. Pathogenic lymphoid cells engineered to express TGF-β1 ameliorate disease in a collagen-induced arthritis model. Gene Ther 1997, 4: 553-9.
31. Robbins, P.D., Evans, C.H. Prospects for treating autoimmune and inflammatory diseases by gene therapy. Gene Ther 1996, 3: 187-9.
32. Doughty, L.A., Patrene, K.D., Evans, C.H., Boggs, S.S., Robbins, P.D. Constitutive expression of IL-1Ra or soluble JNF-α receptor by genetically modified hemtopoietic cells supresses LPS induction of IL-6 and IL-10. Gene Ther 1997, 4: 252-7.
33. Bakker, A.C., Joosten, L.A.B., Arntz, O.J. et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 1997, 40: 893-900.
34. Makarov, S., Baldwin, A.S. Local suppression of NF-κB inhibits experimental arthritis in rat. Arthritis Rheum 1996, 39 (Suppl.): S121.
35. Evans, C.H., Robbins, P.D., Elder, E. et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996; 7: 1261-80.
36. Ghivizzani, S.C., Muzzonigro, T.S., Kang, R., Evans, C.H., Robbins, P.D. Clinical gene therapy for arthritis. Drugs Today 1999, 35(4): 167-74.